A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets
Stopped Per sponsor request. Premature closure was not prompted by any safety or efficacy concerns.
Conditions
- Metastatic Castration-resistant Prostate Cancer
Interventions
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.